To evaluated whether p53 activation contributes to PC loss in human SMA pathology, we performed immunohistochemistry experiments with p-p53S15 antibodies and well-preserved cerebellar sections from a control individual and a Type I SMA patient. This evidence concerns the gene TP53 and proximal spinal muscular atrophy.